EATRIS

EATRIS is a non-profit European Research Infrastructure Consortium (ERIC). This specific legal form is designed to facilitate the joint establishment and operation of research infrastructures of European interest.

The organisational model of EATRIS is based on the unification of European countries with the aim of promoting the development and scientific excellence of translational medicine, the development of new diagnostic methods and drugs and ensuring their implementation in practical medicine in accordance with ethical and regulatory requirements.

Product platforms

• Advanced therapy medical products
• Biomarkers
• Imaging & Tracing
• Small Molecules
• Vaccines
• COVID-19 research

EATRIS has published an update on their response to the COVID-19 pandemic, which also includes an overview of our institutions' activities and services.

Vision

To make the translation of scientific discoveries into medical products more effective in order to improve health and quality of life.

Mission

To support researchers in developing their biomedical discoveries into novel translational tools and interventions for better societal health outcomes.

Aim

To help scientists with the resources they wouldn’t be able to have otherwise, like laboratory equipment, guidance, or other scientific specialties.

Supporting academia, industry, patients and policy makers

EATRIS makes the translational community accessible to researchers by providing:

• Access to quality research infrastructure services;
• Support for multi-disciplinary, patient-oriented research;
• The best infrastructure & resources to ensure the optimal methodological approach;
• Easy access to industry, regulatory expertise;
• The development of new tools for better R&D output.

EATRIS assists in the preparation of project applications:

• By establishing a consortium
• Joining as partner
• Acting as presenter.